Kaempferol inhibits pancreatic cancer cell growth and migration through the blockade of EGFR-related pathway in vitro

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Lee, Jungwhoi ^a   Kim, Jae Hoon ^a  

^a Jeju National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KAEMPFEROL; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; ANTINEOPLASTIC AGENT; KAEMPFEROL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL LINE; CELL GROWTH; CELL MIGRATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; HUMAN; HUMAN CELL; IN VITRO STUDY; MIAPACA 2 CELL LINE; PANC 1 CELL LINE; PANCREAS CANCER; PHARMACOLOGICAL BLOCKING; PROTEIN PHOSPHORYLATION; SNU 213 CELL LINE; BIOLOGICAL MODEL; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; METABOLISM; PANCREAS TUMOR; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL MOVEMENT; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ERBB RECEPTORS; HUMANS; KAEMPFEROLS; MODELS, BIOLOGICAL; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84969903144     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155264     Document Type: Article

References (44)

1. Neoptolemos JP, Dunn JA, Stocken DD, Almond J, Link K, Beger H, et al. (2001) Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet 358: 1576-1585. PMID: 11716884
2. DiMagno EP, Reber HA, Tempero MA (1999) AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma. American Gastroenterological Association. Gastroenterology 117: 1464-1484. PMID: 10579989
3. Kim J, Yu W, Kovalski K, Ossowski L (1998) Requirement for specific proteases in cancer cell intravasation as revealed by a novel semiquantitative PCR-based assay. Cell 94: 353-362. PMID: 9708737
4. Chen AY, Chen YC (2013) A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chem 138: 2099-2107. doi: 10.1016/j.foodchem.2012.11.139 PMID: 23497863
5. Luo H, Jiang BH, King SM, Chen YC (2008) Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr Cancer 60: 800-809. doi: 10.1080/01635580802100851 PMID: 19005980
6. Somerset SM, Johannot L (2008) Dietary flavonoid sources in Australian adults. Nutr Cancer 60: 442-449. doi: 10.1080/01635580802143836 PMID: 18584477
7. Ramos S (2007) Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18: 427-442. PMID: 17321735
8. Kim BW, Lee ER, Min HM, Jeong HS, Ahn JY, Kim JH, et al. (2008) Sustained ERK activation is involved in the kaempferol-induced apoptosis of breast cancer cells and is more evident under 3-D culture condition. Cancer Biol Ther 7: 1080-1089. PMID: 18443432
9. Zhang Y, Chen AY, Li M, Chen C, Yao Q (2008) Ginkgo biloba extract kaempferol inhibits cell proliferation and induces apoptosis in pancreatic cancer cells. J Surg Res 148: 17-23. doi: 10.1016/j.jss.2008. 02.036 PMID: 18570926
10. Jung P, Menssen A, Mayr D, Hermeking H (2008) AP4 encodes a c-MYC-inducible repressor of p21. Proc Natl Acad Sci U S A 105: 15046-15051. doi: 10.1073/pnas.0801773105 PMID: 18818310
11. Luo H, Daddysman MK, Rankin GO, Jiang BH, Chen YC (2010) Kaempferol enhances cisplatin's effect on ovarian cancer cells through promoting apoptosis caused by down regulation of cMyc. Cancer Cell Int 10: 16. doi: 10.1186/1475-2867-10-16 PMID: 20459793
12. Bobe G, Albert PS, Sansbury LB, Lanza E, Schatzkin A, Nancy H, et al. (2010) Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev Res (Phila) 3: 764-775.
13. Ulrich CM, Bigler J, Potter JD (2006) Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 6: 130-140. PMID: 16491072
14. Labbe D, Provencal M, Lamy S, Boivin D, Gingras D, Beliveau R, et al. (2009) The flavonols quercetin, kaempferol, and myricetin inhibit hepatocyte growth factor-induced medulloblastoma cell migration. J Nutr 139: 646-652. doi: 10.3945/jn.108.102616 PMID: 19244381
15. Phromnoi K, Yodkeeree S, Anuchapreeda S, Limtrakul P (2009) Inhibition of MMP-3 activity and invasion of the MDA-MB-231 human invasive breast carcinoma cell line by bioflavonoids. Acta Pharmacol Sin 30: 1169-1176. doi: 10.1038/aps.2009.107 PMID: 19617894
16. Mendelsohn J, Baselga J (2006) Epidermal growth factor receptor targeting in cancer. Semin Oncol 33: 369-385. PMID: 16890793
17. Oliveira-Cunha M, Newman WG, Siriwardena AK (2011) Epidermal growth factor receptor in pancreatic cancer. Cancers (Basel) 3: 1513-1526.
18. Troiani T, Martinelli E, Capasso A, Morgillo F, Orditura M, De Vita F, et al. (2012) Targeting EGFR in pancreatic cancer treatment. Curr Drug Targets 13: 802-810. PMID: 22458527
19. Citri A, Yarden Y (2006) EGF-ERBB signalling: towards the systems level. Nat Rev Mol Cell Biol 7: 505-516. PMID: 16829981
20. Yamanaka Y, Friess H, Kobrin MS, Buchler M, Beger HG, Kork M (1993) Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 13: 565-569. PMID: 8317885
21. Lee J, Hun Yun J, Lee J, Choi C, Hoon Kim J (2015) Blockade of dual-specificity phosphatase 28 decreases chemo-resistance and migration in human pancreatic cancer cells. Sci Rep 5: 12296. doi: 10.1038/srep12296 PMID: 26212664
22. Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. (2014) TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform 6: 13. doi: 10.1186/1758-2946-6-13 PMID: 24735618
23. Lee J, Ku T, Yu H, Chong K, Ryu SW, Choi K, et al. (2012) Blockade of VEGF-A suppresses tumor growth via inhibition of autocrine signaling through FAK and AKT. Cancer Lett 318: 221-225. doi: 10. 1016/j.canlet.2011.12.014 PMID: 22182449
24. Liu T, Song Y, Chen H, Pan S, Sun X (2010) Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biol Pharm Bull 33: 1740-1745. PMID: 20930385
25. Lee J, Han SI, Yun JH, Kim JH (2015) Quercetin 3-O-glucoside suppresses epidermal growth factorinduced migration by inhibiting EGFR signaling in pancreatic cancer cells. Tumour Biol.
26. Lin CW, Chen PN, Chen MK, Yang WE, Tang CH, Yang SF, et al. (2013) Kaempferol reduces matrix metalloproteinase-2 expression by down-regulating ERK1/2 and the activator protein-1 signaling pathways in oral cancer cells. PLoS One 8: e80883. doi: 10.1371/journal.pone.0080883 PMID: 24278338
27. Li C, Zhao Y, Yang D, Yu Y, Guo H, Zhao Z, et al. (2015) Inhibitory effects of kaempferol on the invasion of human breast carcinoma cells by downregulating the expression and activity of matrix metalloproteinase-9. Biochem Cell Biol 93: 16-27. doi: 10.1139/bcb-2014-0067 PMID: 25453494
28. Marfe G, Tafani M, Indelicato M, Sinibaldi-Salimei P, Reali V, Pucci B, et al. (2009) Kaempferol induces apoptosis in two different cell lines via Akt inactivation, Bax and SIRT3 activation, and mitochondrial dysfunction. J Cell Biochem 106: 643-650. doi: 10.1002/jcb.22044 PMID: 19160423
29. Long J, Zhang Y, Yu X, Yang J, LeBrun DG, Chen C, et al. (2011) Overcoming drug resistance in pancreatic cancer. Expert Opin Ther Targets 15: 817-828. doi: 10.1517/14728222.2011.566216 PMID: 21391891
30. Tatsimo SJ, Tamokou Jde D, Havyarimana L, Csupor D, Forgo P, Judit H, et al. (2012) Antimicrobial and antioxidant activity of kaempferol rhamnoside derivatives from Bryophyllum pinnatum. BMC Res Notes 5: 158. doi: 10.1186/1756-0500-5-158 PMID: 22433844
31. Khanduja KL, Bhardwaj A (2003) Stable free radical scavenging and antiperoxidative properties of resveratrol compared in vitro with some other bioflavonoids. Indian J Biochem Biophys 40: 416-422. PMID: 22900369
32. Landolfi R, Mower RL, Steiner M (1984) Modification of platelet function and arachidonic acid metabolism by bioflavonoids. Structure-activity relations. Biochem Pharmacol 33: 1525-1530. PMID: 6329230
33. Boege F, Straub T, Kehr A, Boesenberg C, Christiansen K, Anni A, et al. (1996) Selected novel flavones inhibit the DNA binding or the DNA religation step of eukaryotic topoisomerase I. J Biol Chem 271: 2262-2270. PMID: 8567688
34. Nguyen TT, Tran E, Ong CK, Lee SK, Do PT, Huynh TT, et al. (2003) Kaempferol-induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK-MAPK. J Cell Physiol 197: 110-121. PMID: 12942547
35. Harris DM, Besselink E, Henning SM, Go VL, Heber D (2005) Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells. Exp Biol Med (Maywood) 230: 558-568.
36. Brusselmans K, Vrolix R, Verhoeven G, Swinnen JV (2005) Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem 280: 5636-5645. PMID: 15533929
37. Masters JR (2012) Cell-line authentication: End the scandal of false cell lines. Nature 492: 186.
38. Montana MP, Pappano N, Giordano SO, Molina P, Debattista NB, et al. (2007) On the antioxidant properties of three synthetic flavonols. Pharmazie 62: 72-76. PMID: 17294818
39. Wang L, Tu YC, Lian TW, Hung JT, Yen JH, Wu MJ (2006) Distinctive antioxidant and antiinflammatory effects of flavonols. J Agric Food Chem 54: 9798-9804. PMID: 17177504
40. Jung HA, Jung MJ, Kim JY, Chung HY, Choi JS (2003) Inhibitory activity of flavonoids from Prunus davidiana and other flavonoids on total ROS and hydroxyl radical generation. Arch Pharm Res 26: 809-815. PMID: 14609128
41. Das NP, Pereira (1990) Effects of flavonoids on thermal autoxidation of palm oil: structure-activity relationship. J Am Chem Oil Soc 67: 255-258
42. Casci T (2012) Bioinformatics: Next-generation omics. Nat Rev Genet 13: 378.
43. Di Renzo MF, Poulsom R, Olivero M, Comoglio PM, Lemoine NR (1995) Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res 55: 1129-1138. PMID: 7866999
44. Brandes F, Schmidt K, Wagner C, Redekopf J, Schlitt HJ, Geissler EK, et al. (2015) Targeting cMET with INC280 impairs tumour growth and improves efficacy of gemcitabine in a pancreatic cancer model. BMC Cancer 15: 71. doi: 10.1186/s12885-015-1064-9 PMID: 25884642